anti- CCKAR-specific antibody
Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
anti- CCKAR-specific antibody
category
Primary Antibodies
provider
FineTest
reference
FNab01377
tested applications
ELISA, IHC
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | cholecystokinin A receptor |
| Host | Rabbit |
| Reactivity | human |
| Recommended Dilution | IHC: 1:20-1:200 |
| Clonality | polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | Immunogen affinity purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, IHC |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | P32238 |
| Gene ID | 886 |
| Alias | CCKAR,CCK-1R,CCK-A,CCK1-R,CCK1R,CCKRA,CCK1-R,cholecystokinin receptor type A,cholecystokinin-1 receptor |
| Background | Antibody anti-CCKAR |
| Status | RUO |
| Note | This product is for research use only. |
CCKAR is a G protein-coupled receptor (GPCR) predominantly expressed in the gastrointestinal tract, pancreas, and brain, where it binds the peptide hormone cholecystokinin (CCK) with high affinity. It regulates digestive processes by stimulating gallbladder contraction, pancreatic enzyme secretion, and gastric motility. In the brain, CCKAR is involved in satiety signaling, regulating appetite and feeding behavior by modulating neuronal pathways in the hypothalamus and brainstem. Its activation triggers downstream signaling pathways such as phospholipase C (PLC), calcium mobilization, and protein kinase C (PKC), leading to cellular responses like smooth muscle contraction and enzyme secretion. CCKAR is implicated in metabolic disorders, including obesity, where dysregulated signaling contributes to appetite dysregulation and energy imbalance. It also plays a role in anxiety and mood disorders, as CCK signaling interacts with neurotransmitter systems like dopamine and serotonin. In cancer, CCKAR overexpression has been observed in pancreatic and gastrointestinal cancers, where it enhances cell proliferation and survival. Pharmacological targeting of CCKAR is being explored for obesity, gastrointestinal disorders, and certain cancers. Overall, CCKAR is essential for gastrointestinal function, appetite regulation, and metabolic homeostasis.
Related Products
Human CCKAR(Cholecystokinin A Receptor) ELISA Kit
Ver Producto
Mouse CCKAR(Cholecystokinin A Receptor) ELISA Kit
Ver Producto